Atara Biotherapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.93

-0.30 (-3.65%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 80%

Hold 2 20%

Sell 0 0%

Price Target

Analyst Price Target -11.2% upside

Low Target $5.84

Average Target $7.04

High Target $9.41

Current Price $7.93

Current
$7.93

Target
$7.04

$5.84 $7.04 avg $9.41

Scenario Analysis

Bear Case

$5.84

-26.4%

Low target

Base Case

$7.04

-11.2%

Avg target

Bull Case

$9.41

+18.7%

High target

Risk/Reward

0.7x

Unfavorable

Price in Context

52-Week High

$19.15

-58.6% from high

52-Week Low

$3.92

+102.3% from low

Target vs 52W High

$7.04

-63.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.5%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.5%
MRNA Moderna Inc	Hold	31	32%	$149.45	-35.4%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.9%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.7%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-35.3%